Die NovaPump GmbH ist eine in 2012 gegründete Medizintechnikfirma aus Jena, die Forschung und Entwicklung auf dem Gebiet der katheterbasierten (interventionellen) Herztechnik betreibt und Therapielösungen für die Links- und Rechtsherzpumpunterstützung entwickelt. Dabei fokussiert die neuartige PERKAT Technologie auf die Behandlung von Patienten/innen im kardiogenen Schock und akut dekompensierter Herzinsuffizienz mit Beteiligung auch des rechten Herzens.
Basierend auf etablierten Verfahren der interventionellen Kardiologie, bietet der neuartige Therapieansatz eine sichere pulsatile Unterstützung bei hohen Herz-Zeit-Pumpvolumina.
The NovaPump GmbH is a Venture-Capital financed and technology oriented med-tech company from Jena (Germany, a university town which is to be called the scientific and industrial center of the German Bundesland Thuringia).
NovaPump is focused on catheter based interventional technologies for the current and for the future cardiology.
So specific new therapy options especially for the right (heart) ventricle will be offered. The leading therapy options of NovaPump are focused on intracorporal pulsatile circulation support. The so called PERKAT® technologies are sophisticated, safe and gentle to the patients (trough catheter based techniques) and international leading with is technological parameters. The PERKAT® technologies will help patients with isolated right myocardial infarction, decompensated acute heart insuffiency and cardiogenic shock patients in the ICU. For this patient population the mortality rate (30d) is about 40 percent or higher by now, which has to be improved soon.
PERKAT® technologies base on established procedures of the interventional cardiology (like the IABP technique [Intra Aortic Ballon Pumping]) which are available in all leading heart centres in the EU and in the US. With are patented percutaneous pulsatile technologies it will be possible, to increase the circulation support significantly and bi-ventricular.
We are forward to getting in contact with you. Please note that our PERKAT® technologies are not available on the market by now.